Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma
Clinical trial NCT06308913 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06308913
- Sponsor
- University of Wisconsin, Madison
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-18
- Primary completion
- 2026-10-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.